

The Haematology Patient and Carers Congress 2026
The Haematology Patient and Carers Congress (HPCC26) is the leading patient-centred platform uniting patients, carers, clinicians, researchers, and healthcare leaders working to transform outcomes across the spectrum of blood disorders.
Taking place in May 2026, HPCC26 will provide a unique environment for open dialogue on real-world evidence, integrated care models, equitable access strategies, and the future of patient-partnered research. With a curated programme and participation from over 2,000 patients, 200+ clinicians, 100+ NHS executives, and leading advocacy organisations, this is a must-attend event for those seeking to engage meaningfully with the haematology community and drive lasting system change.
Join us at the intersection of lived experience, clinical innovation, and system leadership.
Patients
2000+

Clinicians
200
NHS Executives
100+
Conditions Represented
15+
Patient Organisations
20+
The Haematology Patient and Carers Congress 2026
The Haematology Patient and Carers Congress (HPCC26) is the leading patient-centred platform uniting individuals, clinicians, researchers, and healthcare leaders working to transform outcomes across the spectrum of blood disorders.
Taking place in May 2026, HPCC26 will provide a unique environment for open dialogue on real-world evidence, integrated care models, equitable access strategies, and the future of patient-partnered research. With a curated programme and participation from over 2,000 patients, 200+ clinicians, 100+ NHS executives, and leading advocacy organisations, this is a must-attend event for those seeking to engage meaningfully with the haematology community and drive lasting system change.
Join us at the intersection of lived experience, clinical innovation, and system leadership.
Patients
2000+

Clinicians
200
NHS Executives
100+
Conditions Represented
15+
Patient Organisations
20+
The Haematology Patient and Carers Congress 2026
The Haematology Patient and Carers Congress (HPCC26) is the leading patient-centred platform uniting individuals, clinicians, researchers, and healthcare leaders working to transform outcomes across the spectrum of blood disorders.
Taking place in May 2026, HPCC26 will provide a unique environment for open dialogue on real-world evidence, integrated care models, equitable access strategies, and the future of patient-partnered research. With a curated programme and participation from over 2,000 patients, 200+ clinicians, 100+ NHS executives, and leading advocacy organisations, this is a must-attend event for those seeking to engage meaningfully with the haematology community and drive lasting system change.
Join us at the intersection of lived experience, clinical innovation, and system leadership.
Patients
2000+

Clinicians
200
NHS Executives
100+
Conditions Represented
15+
Patient Organisations
20+



Sharing Knowledge, Sparking Ideas, and Inspiring Change.

Professor Sue Pavord
President, British Society for Haematology and Consultant Haematologist, Oxford University Hospitals NHS Foundation Trust
.avif)
Sir James Mackey
Chief Executive of NHS England

David Probert
Chief Executive Officer, University College Hospitals London and Deputy Chief Executive Officer, NHS England
.avif)
Professor Claire Harrison
Deputy Chief Medical Officer, Guys and St Thomas’ NHS Foundation Trust
Sharing Knowledge, Sparking Ideas, and Inspiring Change.

Professor Sue Pavord
President, British Society for Haematology and Consultant Haematologist, Oxford University Hospitals NHS Foundation Trust
.avif)
Sir James Mackey
Chief Executive of NHS England

David Probert
Chief Executive Officer, University College Hospitals London and Deputy Chief Executive Officer, NHS England
.avif)
Professor Claire Harrison
Deputy Chief Medical Officer, Guys and St Thomas’ NHS Foundation Trust
Sharing Knowledge, Sparking Ideas, and Inspiring Change.

Professor Sue Pavord
President, British Society for Haematology and Consultant Haematologist, Oxford University Hospitals NHS Foundation Trust
.avif)
Sir James Mackey
Chief Executive of NHS England

David Probert
Chief Executive Officer, University College Hospitals London and Deputy Chief Executive Officer, NHS England
.avif)
Professor Claire Harrison
Deputy Chief Medical Officer, Guys and St Thomas’ NHS Foundation Trust
Empowering Patients and Carers to Lead Change.

Unparalleled Collaboration
Bringing together patients, clinicians, NHS leaders, researchers, and industry partners to shape the future of haematology care through collaboration and shared insight.

A Platform for Innovation
Influence care pathways, accelerate innovation, and champion equity by engaging in sessions designed to deliver measurable change.

Network with Purpose
Meet the people shaping the future of rare, chronic, and haematological care and form connections that lead to real-world collaboration.
Empowering Patients and Carers to Lead Change.

Unparalleled Collaboration
Bringing together patients, clinicians, NHS leaders, researchers, and industry partners to shape the future of haematology care through collaboration and shared insight.

A Platform for Innovation
Influence care pathways, accelerate innovation, and champion equity by engaging in sessions designed to deliver measurable change.

Network with Purpose
Meet the people shaping the future of rare, chronic, and haematological care and form connections that lead to real-world collaboration.
Bigger In Scale, Bolder In Vision, And Elevated In Impact
Building on the resounding success of our 2024 event, the Hematology Patient and Carers Congress 2025 is poised to be Europe’s premier and most impactful gathering yet. We’re raising the bar even higher – delivering world-class speakers, fully immersive experiences, and unmatched networking opportunities that will truly accelerate patient outcomes, access and innovation for the haematology community.
The HPCC25 is set to create an energising atmosphere of learning and advancement. Shared experiences, expertise, and insights will catalyse innovations that increase the potential for developing safer, more effective medicines and care approaches.
Our Previous Keynote Speakers and Clinical Contributors
From haematological leaders to patient representatives, we’re excited to share new speakers for The HPCC’26

Professor Sue Pavord
President, British Society for Haematology and Consultant Haematologist, Oxford University Hospitals NHS Foundation Trust


Sir James Mackey
Chief Executive of NHS England

Professor Claire Harrison
Deputy Chief Medical Officer, Guys and St Thomas’ NHS Foundation Trust

David Probert
Chief Executive Officer, University College Hospitals London and Deputy Chief Executive Officer, NHS England.
About HPCC26
The HPCC25 is set to create an energising atmosphere of learning and advancement. Shared experiences, expertise, and insights will catalyse innovations that increase the potential for developing safer, more effective medicines and care approaches
200+
Clinicians
185
200+
Partners
40
200+
Speakers
27


Our Previous Sponsors
and Partners Include
The HPCC was organised by Sanius Health and sponsored through funding by a number of pharmaceutical companies. These companies have had no involvement in the organisation, agenda or catering of this meeting, with the exception of the sponsored symposium sessions for which the sponsoring company is fully responsible.


The Haematology Patient and Carers Congress 2026: Set in the Iconic Central Hall, Westminster, London

Set within the iconic Central Hall Westminster, a Grade II* listed venue in the heart of London with unrivalled views of Westminster Abbey, HPCC26 promises a world-class platform for shaping the future of blood cancer research.

















































The HPCC and KOL have been organised by Sanius Health and sponsored through funding by a number of pharmaceutical companies. These companies have had no involvement in the organisation, agenda, or catering of this meeting, with the exception of the sponsored symposium sessions for which the sponsoring company is fully responsible.
From wellness activities to curated items, we’re grateful to the brands adding a little something special to the HPCC experience.
Our 2025 Partners
The HPCC and KOL have been organised by Sanius Health and sponsored through funding by a number of pharmaceutical companies. These companies have had no involvement in the organisation, agenda, or catering of this meeting, with the exception of the sponsored symposium sessions for which the sponsoring company is fully responsible.
From wellness activities to curated items, we’re grateful to the brands adding a little something special to the HPCC experience.
Our 2025 Partners
































Insights That Shaped Our Mission
Each year, the HPCC brings together patients, clinicians, researchers, and advocates to push the boundaries of what's possible. From stories of lived experience to groundbreaking research in gene therapy and patient-driven data, HPCC have shaped not only conversations—but real change.
Equitable Access to Care
The summit emphasized that access is not just about treatment availability—it’s about timely, inclusive, and patient-recognized care.
Improved Outcomes through Real-World Data
A major takeaway was the importance of combining clinical data with lived patient experiences to create better, more personalized health outcomes.
Patient-Centered Research
The role of patient-generated data was a recurring theme—it's no longer supplemental but foundational to the next era of haematology research.

Insights That Shaped Our Mission
Each year, the HPCC brings together patients, clinicians, researchers, and advocates to push the boundaries of what's possible. From stories of lived experience to groundbreaking research in gene therapy and patient-driven data, HPCC has shaped not only conversations but real change.
1.

Patient-Centered Research
2.

Equitable Access to Care
3.

Improved Outcomes through Real-World Data
4.

Innovation in Therapies
Insights That Shaped Our Mission
Each year, the HPCC brings together patients, clinicians, researchers, and advocates to push the boundaries of what's possible.
From stories of lived experience to groundbreaking research in gene therapy and patient-driven data, HPCC has shaped not only conversations but real change.
1.
.jpg)
Patient-Centered Research
2.

Equitable Access to Care
3.

Improved Outcomes through Real-World Data
4.

Innovation in Therapies
Insights That Shaped Our Mission
Each year, the HPCC brings together patients, clinicians, researchers, and advocates to push the boundaries of what's possible. From stories of lived experience to groundbreaking research in gene therapy and patient-driven data, HPCC have shaped not only conversations—but real change.

Equitable Access to Care

Patient-Centered Research

Improving Outcomes with Real-World Data
Insights That Shaped Our Mission
Each year, the HPCC brings together patients, clinicians, researchers, and advocates to push the boundaries of what's possible. From stories of lived experience to groundbreaking research in gene therapy and patient-driven data, HPCC have shaped not only conversations but real change.
1.

Patient-Centered Research
2.

Equitable Access to Care
3.

Improved Outcomes through Real-World Data
4.
